Merck

Merck initiates cash tender offer to buy Imago BioSciences
Pharmaceutical Business Review
Tue, 12/13/22 - 10:26 am
Merck
M&A
Imago BioSciences
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
ASH 2022
AstraZeneca
Janssen
Merck
Vega Therapeutics
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Mirati Therapeutics
adagrasib
Merck
Keytruda
metastatic lung cancer
lung cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs
BioSpace
Tue, 11/29/22 - 08:25 pm
Merck
BigHat Biosciences
R&D
artificial intelligence
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Merck
Keytruda
clinical trials
adenocarcinoma
Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis
Fierce Biotech
Mon, 11/21/22 - 10:34 am
Merck
M&A
Imago BioSciences
blood cancer
Gossamer could put pressure on Merck
EP Vantage
Fri, 11/11/22 - 10:26 am
Merck
Gossamer Bio
PAH
sotatercept
United Therapeutics
ralinepag
Sotatercept- the breakthrough PAH has been waiting for?
Clinical Trials Arena
Thu, 11/10/22 - 10:31 am
Merck
sotatercept
Acceleron
PAH
Is Merck Too Dependent on Keytruda?
Motley Fool
Wed, 11/9/22 - 10:50 am
Merck
Keytruda
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Regeneron
Libtayo
non-small cell lung cancer
Keytruda
Merck
Gilead, Arcus slim phase 3 TIGIT trial to take on king Keytruda
Fierce Biotech
Thu, 11/3/22 - 11:10 am
Gilead Sciences
ARCUS
clinical trials
Merck
Keytruda
domvanalimab
zimberelimab
non-small cell lung cancer
A timeline of Ken Frazier’s tenure at Merck
Medical Marketing and Media
Sun, 10/30/22 - 04:13 pm
Kenneth Frazier
Merck
Pharma CEOs
Merck CEO Rob Davis has business development on the brain as he builds 'pipeline of the future'
Endpoints
Fri, 10/28/22 - 10:22 am
Merck
Rob Davis
Pharma CEOs
M&A
Kenneth Frazier announces retirement after decades at Merck
Medical Marketing and Media
Thu, 10/27/22 - 08:26 pm
Merck
Kenneth Frazier
Pharma CEOs
Merck Stock Jumps As Keytruda Sales Power Q3 Earnings Beat, Profit Forecast Boost
TheStreet.com
Thu, 10/27/22 - 10:46 am
Merck
earnings
MS Drug Advances from Merck, BMS and More Showcased at ECTRIMS Conference
BioSpace
Wed, 10/26/22 - 06:51 pm
Merck
Biogen
Bristol Myers Squibb
MS
multiple sclerosis
ECTRIMS
Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool
Wed, 10/26/22 - 10:32 am
Merck
sotatercept
PAH
Merck fined $38M in Spain for hindering generic competition for NuvaRing
Fierce Pharma
Tue, 10/25/22 - 11:07 pm
Merck
Spain
anti-competitive scheme
Merck tees up Prevymis filing in kidney transplant recipients after phase 3 trial win
Fierce Pharma
Mon, 10/24/22 - 10:56 am
Merck
Prevymis
kidney transplants
clinical trials
CMV
IDWeek

Pages